Replicel Life Sciences Inc
XTSX:RP

Watchlist Manager
Replicel Life Sciences Inc Logo
Replicel Life Sciences Inc
XTSX:RP
Watchlist
Price: 0.015 CAD Market Closed
Market Cap: 954.8k CAD
Have any thoughts about
Replicel Life Sciences Inc?
Write Note

Replicel Life Sciences Inc
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Replicel Life Sciences Inc
Total Current Liabilities Peer Comparison

Comparables:
ABCL
ARCH
IOT

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Replicel Life Sciences Inc
XTSX:RP
Total Current Liabilities
CA$1.5m
CAGR 3-Years
-18%
CAGR 5-Years
-5%
CAGR 10-Years
15%
Abcellera Biologics Inc
NASDAQ:ABCL
Total Current Liabilities
$119m
CAGR 3-Years
5%
CAGR 5-Years
79%
CAGR 10-Years
N/A
Arch Biopartners Inc
XTSX:ARCH
Total Current Liabilities
CA$7.6m
CAGR 3-Years
23%
CAGR 5-Years
92%
CAGR 10-Years
32%
Innovotech Inc
XTSX:IOT
Total Current Liabilities
CA$171.1k
CAGR 3-Years
21%
CAGR 5-Years
0%
CAGR 10-Years
-13%

See Also

What is Replicel Life Sciences Inc's Total Current Liabilities?
Total Current Liabilities
1.5m CAD

Based on the financial report for Sep 30, 2023, Replicel Life Sciences Inc's Total Current Liabilities amounts to 1.5m CAD.

What is Replicel Life Sciences Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
15%

Over the last year, the Total Current Liabilities growth was -18%. The average annual Total Current Liabilities growth rates for Replicel Life Sciences Inc have been -18% over the past three years , -5% over the past five years , and 15% over the past ten years .

Back to Top